SMSamuel R. McKee

Samuel R. McKee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuel R. McKee has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Asya Smirnov

    Department of Molecular Microbiology, Washington University School of Medicine

    2 shared publications
  • Chanchal Sur Chowdhury

    Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA

    2 shared publications
  • Christina Leigh Stallings

    Department of Molecular Microbiology, Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO 63110, USA

    2 shared publications
  • Darren Kreamalmeyer

    Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA

    2 shared publications
  • Maxim N. Artyomov

    Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA

    2 shared publications
  • Aaron Pride

    Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA

    1 shared publication

Latest Publications

  • ATG5 suppresses type I IFN-dependent neutrophil effector functions during Mycobacterium tuberculosis infection in mice

    by Rachel L. Kinsella, Chanchal Sur Chowdhury, Asya Smirnov, Yassin Mreyoud, Jacqueline M. Kimmey, Ekaterina Esaulova, Samuel R. McKee, Aaron Pride, Darren Kreamalmeyer, Maxim N. Artyomov, et al.

    Inflammation is critical for controlling infections but can cause disease when unchecked. During Mycobacterium tuberculosis (Mtb) infection, neutrophil-dominated inflammation is associated with exacerbated disease. ATG5 expression by neutrophils mediates autophagy-independent control of infection but mechanistic understanding of how this regulates protective neutrophil function is lacking. Using genetic mouse models along with in vivo and in vitro infection systems, we report herein that ATG5 is required in neutrophils to suppress type I interferon-induced PAD4-mediated histone citrullination and neutrophil extracellular trap (NET) release. In addition, ATG5 suppresses type I interferon-induced CXCL2 secretion and neutrophil swarming during Mtb infection. Elevated type I IFN signalling and NET release contribute to the early susceptibility of Atg5fl/fl-LysM-Cre mice during infection. These findings identify ATG5 as a master regulator of how type I interferon influences neutrophil responses during infection, revealing a potential target for host-directed therapies.


  • Top Cited Papers

    Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice

    by Siwei Feng, Michael E. McNehlan, Rachel L. Kinsella, Chanchal Sur Chowdhury, Sthefany M. Chavez, Sumanta K. Naik, Samuel R. McKee, Jacob A. Van Winkle, Neha Dubey, Amanda Samuels, et al.

    Although autophagy sequesters Mycobacterium tuberculosis (Mtb) in in vitro cultured macrophages, loss of autophagy in macrophages in vivo does not result in susceptibility to a standard low-dose Mtb infection until late during infection, leaving open questions regarding the protective role of autophagy during Mtb infection. Here we report that loss of autophagy in lung macrophages and dendritic cells results in acute susceptibility of mice to high-dose Mtb infection, a model mimicking active tuberculosis. Rather than observing a role for autophagy in controlling Mtb replication in macrophages, we find that autophagy suppresses macrophage responses to Mtb that otherwise result in accumulation of myeloid-derived suppressor cells and subsequent defects in T cell responses. Our finding that the pathogen-plus-susceptibility gene interaction is dependent on dose has important implications both for understanding how Mtb infections in humans lead to a spectrum of outcomes and for the potential use of autophagy modulators in clinical medicine.